Open original FDA record ↗Recall record
- FDA identifier
- Z-1218-03
- Company in FDA record
- Abbott Laboratories HPD/ADD/GPRD
- FDA classification date
- Sep 11, 2003
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
There is a kit-to-kit difference within the lots, with the reagents generating different polarization values than those in others.
Source facts
- Action
- Recall letters dated 8/22/03 informed users of the kit to kit difference within the lots, and outlined the actions needed to take for patient results obtained from the use of the affected kits. The customers were requested to destroy any remaining inventory of the affected reagents. Any questions were directed to Abbott's Customer Service at 1-877-422-2688.
- Initiated
- 2003-08-22
- Root cause
- Other
- Terminated
- 2004-07-20
- Distribution
- Lot 01724M300 was distributed nationwide, as well as to Canada, Singapore, Tahiland, Korea, Hong Kong and China. Lots 03314HN00 and 03533HN00 were distributed by Abbott's Delkenheim, Germany subsidiary worldwide outside of the United States. These two lots were not distributed in the U.S.
- Recall number
- Z-1218-03
- Recall status
- Terminated
- CDRH record ID
- 29126
- FDA classified
- 2003-09-11
- Recall event number
- 27069